HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter C van Rijen Selected Research

Brain-Computer Interfaces

6/2010Brain-computer interfacing based on cognitive control.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter C van Rijen Research Topics

Disease

18Epilepsy (Aura)
11/2022 - 02/2004
13Focal Cortical Dysplasia
10/2021 - 06/2003
11Drug Resistant Epilepsy
01/2022 - 09/2003
11Seizures (Absence Seizure)
01/2022 - 04/2009
11Tuberous Sclerosis (Bourneville's Disease)
01/2022 - 06/2009
7Temporal Lobe Epilepsy
11/2022 - 01/2006
5Inflammation (Inflammations)
10/2021 - 01/2012
4Malformations of Cortical Development
01/2014 - 11/2004
4Ganglioglioma
01/2013 - 09/2003
3Inborn Genetic Diseases (Disease, Hereditary)
01/2022 - 01/2017
3Hippocampal Sclerosis
10/2021 - 01/2006
2Intellectual Disability (Idiocy)
01/2022 - 01/2017
2Rupture
01/2020 - 01/2016
1Autism Spectrum Disorder
01/2022
1Neurodevelopmental Disorders
10/2021
1Status Epilepticus (Complex Partial Status Epilepticus)
10/2021
1Arteriovenous Malformations (Arteriovenous Malformation)
01/2020
1Hemimegalencephaly
01/2019
1Encephalitis (Encephalitis, Rasmussen)
01/2019
1Neuroinflammatory Diseases
01/2019
1Autistic Disorder (Autism)
01/2017
1Intracranial Aneurysm (Cerebral Aneurysm)
01/2016
1Aneurysm (Aneurysms)
01/2016
1Nervous System Diseases (Neurological Disorders)
01/2012
1Paralysis (Palsy)
06/2010
1Ganglioneuroma
06/2007
1Neuroepithelial Neoplasms (Gliomatosis Cerebri)
11/2004
1Neoplasms (Cancer)
09/2003

Drug/Important Bio-Agent (IBA)

9trans-sodium crocetinate (crocetin)IBA
01/2022 - 06/2009
5Anticonvulsants (Antiepileptic Drugs)IBA
12/2018 - 11/2009
3mitomycin C-dextranIBA
12/2019 - 01/2019
3MicroRNAs (MicroRNA)IBA
01/2019 - 01/2012
3Proteins (Proteins, Gene)FDA Link
01/2019 - 09/2003
2Biomarkers (Surrogate Marker)IBA
11/2022 - 09/2015
2TOR Serine-Threonine KinasesIBA
10/2021 - 01/2014
2AntioxidantsIBA
10/2021 - 01/2019
2Mechanistic Target of Rapamycin Complex 1IBA
10/2021 - 01/2017
2RNA (Ribonucleic Acid)IBA
01/2020 - 01/2016
1Cell Adhesion MoleculesIBA
01/2022
1Carrier Proteins (Binding Protein)IBA
01/2022
1Circular RNAIBA
01/2022
1IronIBA
10/2021
1AntagomirsIBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2018
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2018
1Immunoglobulins (Immunoglobulin)IBA
01/2016
1LigandsIBA
04/2011
1Toll-Like Receptor 4IBA
04/2011
1Toll-Like Receptor 2IBA
04/2011
1Toll-Like Receptors (Toll-Like Receptor)IBA
04/2011
1HMGB1 Protein (HMG1)IBA
04/2011
1Receptor for Advanced Glycation End ProductsIBA
04/2011
12- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
06/2010
1Vesicular Glutamate Transport Protein 1IBA
07/2009
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2008
1Metabotropic Glutamate 5 ReceptorIBA
01/2006
1Immune Sera (Antisera)IBA
01/2006
1Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
11/2004
12,6-dinitrotoluene (DNT)IBA
11/2004
1major vault proteinIBA
09/2003
1N 30IBA
09/2003
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
06/2003

Therapy/Procedure

3Therapeutics
10/2021 - 04/2009
3Electrodes (Electrode)
06/2010 - 02/2004
1Hemispherectomy
03/2011
1Brain-Computer Interfaces
06/2010
1Anterior Temporal Lobectomy
11/2009
1Activities of Daily Living (ADL)
03/2007